Balasa Dinverno & Foltz’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$1.69M Sell
3,711
-35
-0.9% -$15.9K 0.11% 80
2022
Q2
$1.81M Sell
3,746
-40
-1% -$19.3K 0.11% 74
2022
Q1
$1.86M Buy
3,786
+788
+26% +$387K 0.13% 74
2021
Q4
$1.39M Sell
2,998
-106
-3% -$49.1K 0.09% 99
2021
Q3
$1.16M Buy
3,104
+117
+4% +$43.6K 0.08% 109
2021
Q2
$1.14M Sell
2,987
-11
-0.4% -$4.2K 0.08% 113
2021
Q1
$1.08M Sell
2,998
-387
-11% -$139K 0.09% 108
2020
Q4
$1.09M Buy
3,385
+243
+8% +$78K 0.09% 97
2020
Q3
$844K Buy
3,142
+165
+6% +$44.3K 0.08% 108
2020
Q2
$783K Sell
2,977
-141
-5% -$37.1K 0.09% 99
2020
Q1
$708K Sell
3,118
-609
-16% -$138K 0.09% 105
2019
Q4
$1.13M Sell
3,727
-672
-15% -$203K 0.12% 85
2019
Q3
$1.06M Buy
4,399
+68
+2% +$16.3K 0.12% 86
2019
Q2
$1.22M Sell
4,331
-584
-12% -$165K 0.14% 70
2019
Q1
$1.41M Buy
4,915
+216
+5% +$62K 0.17% 54
2018
Q4
$1.23M Buy
4,699
+893
+23% +$235K 0.15% 62
2018
Q3
$1.04M Buy
3,806
+176
+5% +$48.2K 0.12% 73
2018
Q2
$864K Buy
3,630
+97
+3% +$23.1K 0.13% 74
2018
Q1
$776K Buy
3,533
+101
+3% +$22.2K 0.12% 76
2017
Q4
$772K Buy
3,432
+102
+3% +$22.9K 0.11% 78
2017
Q3
$632K Buy
3,330
+240
+8% +$45.6K 0.1% 92
2017
Q2
$581K Buy
3,090
+253
+9% +$47.6K 0.09% 96
2017
Q1
$469K Buy
2,837
+74
+3% +$12.2K 0.08% 109
2016
Q4
$397K Sell
2,763
-364
-12% -$52.3K 0.07% 121
2016
Q3
$392K Buy
3,127
+6
+0.2% +$752 0.07% 116
2016
Q2
$410K Sell
3,121
-1,154
-27% -$152K 0.07% 108
2016
Q1
$594K Buy
4,275
+277
+7% +$38.5K 0.11% 74
2015
Q4
$557K Sell
3,998
-3,045
-43% -$424K 0.09% 81
2015
Q3
$986K Buy
7,043
+96
+1% +$13.4K 0.17% 44
2015
Q2
$1.14M Buy
6,947
+1,795
+35% +$295K 0.19% 35
2015
Q1
$796K Buy
5,152
+2,209
+75% +$341K 0.11% 56
2014
Q4
$370K Buy
+2,943
New +$370K 0.05% 122